RNA
#3710
Atrium Therapeutics, Inc. - Common Stock
8.2 1 USD
-0.02%
Market Price
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
Faixa anual
Mudança diária
-2.26%
Mudança mensal
-20.83%
Mudança em 6 meses
-38.27%
Mudança anual
-88.33%
Fechamento anterior
8.4 0
Open
8.4 0
Mínimo
8.2 1
Máximo
8.4 8
Financials
- Market Capitalization 140.44 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotecnologia
Related tickers
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 3693 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.02 USD | -5.61% | -5.61% | -30.58% | -2.88% | 146.08 M USD | ||
| 3702 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.59 USD | -1.67% | -1.67% | -9.23% | +43.03% | 143.63 M USD | ||
| 3712 |  AVXL Anavex Life Sciences Corp. - Common Stock | 1.51 USD | +1.34% | -9.04% | -42.15% | -82.40% | 139.97 M USD | ||
| 3713 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 2.27 USD | -7.35% | -7.72% | -28.39% | -51.18% | 139.87 M USD |